RANI
Rani Therapeutics Holdings, Inc.
+0.09 (+12.43%)0.85USD410K成交股數159M市值–本益比(近四季)32.6股價營收比–營收年增(近四季)2026-11-05下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 1.7M+893% | 1.7M+66% | 0 | 0 | 172K | 1.0M | 0 | 0 | 0 | – | – | – |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 5.0M | 5.2M | 3.2M | 5.5M | 6.6M | 6.8M | 6.2M | 6.1M | 7.6M | 11.2M | 11.1M | 9.7M |
| 銷售管理費用 | 5.5M | 4.9M | 4.0M | 5.0M | 5.6M | 5.5M | 5.6M | 6.4M | 6.4M | 6.6M | 7.2M | 6.8M |
| 營業利益 | −8.8M-27% | −8.3M-44% | −7.3M-38% | −10.5M-16% | −12.0M-14% | −15.0M-16% | −11.8M-36% | −12.5M-24% | −14.0M | −17.9M | −18.3M | −16.5M |
| 營業利益率 | -516.9% | -488.2% | – | – | -6,984.3% | -1,455.0% | – | – | – | – | – | – |
| 稅後淨利 | −7.4M+2% | −7.0M-21% | −5.4M-20% | −6.7M-2% | −7.3M-3% | −8.9M-3% | −6.8M-27% | −6.8M-19% | −7.5M | −9.2M | −9.3M | −8.4M |
| 淨利率 | -432.7% | -411.8% | – | – | -4,223.3% | -870.3% | – | – | – | – | – | – |
| 稀釋 EPS | -0.04-82% | -0.04-85% | -0.12-50% | -0.18-31% | -0.22-24% | -0.26-28% | -0.24-35% | -0.26-21% | -0.29 | -0.36 | -0.37 | -0.33 |
| 稀釋股數 | 187M | 180M | 46.4M | 36.5M | 33.4M | 28.5K | 28.8M | 26.3M | 26.0M | 25.6M | 25.3M | 25.2M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 4.9M | 9.6M | 4.1M | 10.2M | 10.1M | 3.8M | 4.3M | 4.5M | 6.9M | 5.0M | 7.6M | 19.0M |
| 應收帳款 | 2.0M | 2.0M | – | – | 600K | 0 | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 60.8M | 51.9M | 10.1M | 16.9M | 24.1M | 36.6M | 43.5M | 43.7M | 53.5M | 70.4M | 83.5M | 96.4M |
| 有息負債 | – | – | 0 | 2.2M | 5.9M | 9.6M | 13.5M | 17.2M | 20.9M | 28.1M | 29.3M | 29.2M |
| 總負債 | 12.9M | 16.3M | 22.1M | 26.1M | 29.5M | 33.1M | 37.8M | 38.2M | 39.0M | 35.6M | 35.3M | 34.9M |
| 股東權益 | 39.2M | 28.4M | −7.9M | −5.6M | −3.1M | 2.0M | 3.1M | 2.8M | 7.4M | 17.6M | 24.1M | 30.7M |
| 負債比 | 21.1% | 31.5% | 218.1% | 154.2% | 122.2% | 90.5% | 86.7% | 87.3% | 72.8% | 50.6% | 42.3% | 36.1% |
| 淨現金(現金 − 有息負債) | – | – | 4.1M | 8.0M | 4.2M | −5.9M | −9.3M | −12.7M | −14.0M | −23.1M | −21.7M | −10.2M |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −6.5M | – | – | −8.1M-13% | – | – | – | −9.4M | – | – | −12.2M |
| 資本支出 | – | 15K | – | – | 51K | – | – | – | 18K | – | – | 248K |
| 自由現金流 | – | −6.5M | – | – | −8.2M-13% | – | – | – | −9.4M | – | – | −12.4M |
| 折舊攤銷 | – | 161K | – | – | 251K | – | – | – | 248K | – | – | 188K |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | -381.3% | – | – | -4,767.4% | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 1.6M | +58.9% | −29.7M | -1,817.1% | -0.45 | −18.8M |
| FY2024 | 1.0M | – | −30.0M | -2,920.0% | -1.05 | −35.8M |
| FY2023 | 0 | – | −34.0M | –% | -1.33 | −52.5M |
| FY2022 | 0 | -100.0% | −30.6M | –% | -1.28 | −48.1M |
| FY2021 | 2.7M | +488.1% | −8.3M | -306.6% | -0.43 | −32.8M |
| FY2020 | 462K | – | −16.7M | -3,615.4% | – | −16.2M |